ASND · Ascendis Pharma A/S · Documents

$238.90 +4.57 (+1.95%)

Market Cap

$15.69B

65.80M

Volume · Oct 21 662.12K Avg daily vol (3M) 688.48K

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2024-09-03	2024-06-30
6-K	—	2024-08-14	—
6-K	—	2024-08-12	—
6-K	—	2024-07-10	—
6-K	—	2024-06-28	—
6-K	—	2024-06-12	—
6-K	—	2024-05-31	—
6-K	—	2024-05-16	—
6-K	—	2024-05-14	—
6-K	—	2024-05-02	—
6-K	—	2024-05-02	—
6-K	—	2024-05-02	2024-03-31
6-K	—	2024-04-24	—
6-K	—	2024-04-10	—
6-K	—	2024-03-27	2024-03-26
6-K	—	2024-03-14	—
6-K	—	2024-02-29	—
6-K	—	2024-02-14	—
20-F	—	2024-02-07	2023-12-31
6-K	—	2024-02-07	—
6-K	—	2024-01-31	—
6-K	—	2024-01-29	—
6-K	—	2024-01-10	—
6-K	—	2024-01-08	—
6-K	—	2024-01-08	—
6-K	—	2024-01-02	2023-12-29
6-K	—	2023-12-20	—
6-K	—	2023-12-19	—
6-K	—	2023-12-13	—
6-K	—	2023-12-11	—
6-K	—	2023-11-29	—
6-K	—	2023-11-29	—
6-K	—	2023-11-20	—
6-K	—	2023-11-16	2023-11-15
6-K	—	2023-11-16	—
6-K	—	2023-11-07	2023-09-30
6-K	—	2023-11-07	—
6-K	—	2023-10-11	—
6-K	—	2023-09-29	—
6-K	—	2023-09-14	—
6-K	—	2023-09-13	—
6-K	—	2023-09-05	2023-06-30
6-K	—	2023-09-05	—
6-K	—	2023-09-05	—
6-K	—	2023-09-05	—
6-K	—	2023-08-09	—
6-K	—	2023-07-12	—
6-K	—	2023-06-30	—
6-K	—	2023-06-20	—
6-K	—	2023-06-20	—

Showing 101–150 of 299 filings

Key facts CIK 1612042 CUSIP K08588103 13F (30d) 32 filings 32 filers Visit website Investor relations